2m 2m 2m 2m 2m 2m 2m
ELOXX PHARMACT (ELOX)
NASDAQ
$12.99-$0.02 (-0.15%)
Price as of Nov 11, 2026 7:56 PM EST- $44.7MMarket Cap
- 118,272,627.27%1-Year Change
- BiotechnologyIndustry
ELOXX PHARMACT (ELOX)
$12.99-$0.02 (-0.15%)
ELOX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $13.01 | ||
Change | +$0.11 (+0.85%) | ||
Open | $12.50 | ||
High | $13.47 | ||
Low | $12.50 | ||
Previous Close | $12.90 | ||
Volume | 23,950 | ||
30-Day Average Volume | 25,813 | ||
1-Week Change | 2.12% | ||
1-Month Change | -5.31% | ||
1-Year Change | 118,272,627.27% | ||
3-Year Change | -0.19% | ||
5-Year Change | -97.78% | ||
Fundamentals | |||
Shares Outstanding | 3.4M | ||
Total Assets | $63.4M | ||
Market Cap | $44.7M | ||
Enterprise Value | -$14.9M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$4.5M | ||
Free Cash Flow | -$4.8M | ||
EBIT | -$4.5M | ||
EBITDA | -$4.5M | ||
Net Working Capital | $46.4M | ||
EPS | -$0.66 | ||
Enterprise Value/EBITDA | 3 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -20 | ||
PEG | 0 | ||
Price/Free Cash Flow | -9 | ||
Price/Operating Cash Flow | -9 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 11 | ||
Last Split Date | 06/01/2026 | ||
Earnings & Revenue